Your Insurance Denied a GLP-1 — What Happens Now

The first thing to do is unglamorous: read the letter properly, including the part in smaller type.

Under United States rules, a plan denying coverage has to tell you why, and has to tell you how to appeal and by when. That notice — sometimes called an explanation of benefits, an adverse benefit determination or a denial notice — contains the specific reason code or wording, the deadline for appealing, and the contact route.

Those deadlines are the part people lose. Appeal windows are finite and they begin from the date of the notice rather than from the date you got round to reading it.

So: find the reason, find the deadline, and write both down before you do anything else. Almost every good outcome in this situation starts from those two facts.

Prior authorization not on file. Your plan requires approval before it will cover the medication, and either nothing was submitted or the submission was incomplete. This is the most common and often the easiest to resolve, because it is a paperwork gap rather than a refusal.

Not on formulary, or excluded for this use. Your plan's drug list either does not include this product, or includes it only for certain indications. Plans that cover a GLP-1 for type 2 diabetes but exclude weight-management use are common, and that is a plan design choice rather than a clinical judgment about you.

Step therapy. The plan requires you to try one or more alternatives first, and to have that documented.

Quantity limits, or a dispensing rule. The amount or frequency requested exceeds what the plan will cover in a period.

Administrative. Wrong code, wrong pharmacy network, expired authorization, eligibility gap. Genuinely common and genuinely fixable.

General information about insurers is close to useless here, because coverage is set at the plan level. Two people with the same insurer's logo on their card can have entirely different drug coverage.

The documents that govern your case are your plan's formulary or drug list, which states what is covered and under what conditions, and your Evidence of Coverage, Summary of Benefits or plan booklet, which states the rules and the appeal process. Both are usually available through your plan's member portal, and both can be requested in writing.

If you have Medicare Part D, medicare.gov publishes the coverage determination and appeals process directly, including the timelines. If you have a Marketplace plan, HealthCare.gov sets out internal appeals and external review. If your coverage comes through an employer, the US Department of Labor publishes the rules that apply to employer-sponsored plans. Those are the primary sources, and they are the ones to read.

The general structure, though the details depend on your plan type, is a two-stage one.

First an internal appeal, where you ask the plan to reconsider. This normally requires a written request within a stated deadline, and it is usually accompanied by supporting information from your prescriber. Expedited handling is generally available where waiting would be harmful.

If the internal appeal is unsuccessful, many plans are subject to external review by an independent body whose decision the plan must follow. HealthCare.gov describes this for Marketplace coverage, and your state insurance department administers external review for many other plans.

Also common, and often faster than a full appeal, is a formulary exception request: asking the plan to cover a non-preferred or excluded medication in your specific case, supported by a statement from your prescriber. Ask which route applies to your denial rather than assuming.

Be organized about it. Keep copies, note who you spoke to and when, and confirm anything important in writing.

Much of this process happens between the plan and the prescribing office rather than with you, which is genuinely good news.

They can submit or resubmit a prior authorization with the clinical detail the plan wants. They can write a letter of medical necessity, which is the document that most often changes an outcome and which only they can produce. They can document a step-therapy history, including alternatives you have already tried and how those went. In many cases they can request a peer-to-peer review, where the prescriber speaks directly to a clinician at the plan.

Many practices have staff who do this daily and are considerably better at it than any individual patient will be.

What helps them is precision from you: a copy of the denial notice, the reason stated, the deadline, and an accurate history of what you have tried and when. That last part is where your own records earn their keep.

Alongside the appeal, there are other routes people ask about, and it is worth being careful about them.

Manufacturers of GLP-1 products operate their own savings, self-pay and patient support programs, and they publish the current terms, eligibility rules and prices on their own official sites. Those terms change, sometimes frequently, and eligibility often excludes people with government insurance. Go to the manufacturer's official page rather than relying on a figure quoted anywhere else, including here — we deliberately quote no prices.

Your pharmacist can also tell you what the actual cash price would be, whether a different pack or a different pharmacy changes it, and whether there is a covered alternative your prescriber could consider.

What we would advise against is buying from sources outside the regulated pharmacy system. The FDA publishes warnings about counterfeit and unapproved versions of these medicines sold online, and that risk is real. If cost is the pressure, say so to your prescriber and your pharmacist — they hear it constantly and it is not something to be embarrassed about.

Let us be clear about the boundary, because this is an area where an app could easily overclaim.

GLP-1 Tracker has no role in a coverage decision. It cannot file an appeal, does not know your plan, cannot read a formulary, has no relationship with any insurer and provides no financial, legal or insurance advice of any kind.

What it can do is hold the history that sometimes matters as evidence. If your prescriber is documenting adherence, a continuous record of dose dates is more persuasive than a recollection. If they are documenting response, a weight trend over months is a cleaner picture than two readings taken a year apart. If a step-therapy history is at issue, your notes on what you tried and how it went are a starting point for their letter.

That is the whole contribution: better raw material for the people who are actually doing the work. The appeal belongs to you, your prescriber and your plan.